דפגליפלוזין סנדוז 5 מ"ג - Dapagliflozin sandoz 5 mg
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
- ××פ××××פ××××× ×ש×××× ××××× ×§××ר×ת ת×ר×ת ××פ××× ×©× ×¡××רת ×ס×× 2
- ×שפעת ×××פ×× ×¢× ××פ××××פ××××× ×¢× ×××× ×× ×¡×¤×קת ×× ×ס××××× ×ש×ר×ר××ת
- ××××צ×ת ×××ש×ת ×××ª× ××¢××× SGLT2 ××××× ×¡××רת ס×× 1
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Type 2 diabetes mellitus Dapagliflozin Sandoz is indicated in adults aged 18 years and older for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise⢠as monotherapy when metformin is considered inappropriate due to intolerance.⢠in addition to other medicinal products for the treatment of type 2 diabetes.Heart Failure Dapagliflozin Sandoz is indicated in adults for the treatment of symptomatic chronic heart failure Chronic kidney disease Dapagliflozin Sandoz is indicated in adults for the treatment of chronic kidney disease. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×פ×××פ××××× ×¡× ××× 5 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | SANDOZ AG, SWITZERLAND |
| ×©× ××¢× ×ר×ש×× | SANDOZ PHARMACEUTICALS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 11/2022. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 25/01/2025 |
השינוי האחרון נעשה בֹ־23 בספטמבר 2025 ב־02:53